The Cannabis ETF

Why Invest in the WEED ETF

Roundhill believes that continued legalization by both U.S. states and foreign governments globally result in an attractive growth profile for the cannabis sector.

ETF Details

as of TBD

Ticker WEED
Primary Exchange Cboe BZX
Gross Expense Ratio 0.75%
Net Expense Ratio 0.59%*
Shares Outstanding TBD
Launch 4/20/2022
# of Holdings TBD
ETF Options YES
Securities Lending NO

Thematic Relevance


Geographic Breakdown


Market Capitalization Breakdown

Investment Strategy:

The Roundhill Cannabis ETF ("WEED ETF") is designed to offer investors exposure to the cannabis sector. The fund invests in various cannabis related companies, including: (i) cannabis producers and distributors, (ii) cannabis-related technology companies, and (iii) additional cannabis related ancillary businesses.

The Roundhill Cannabis ETF may utilize total return swaps to provide exposure to U.S. focused cannabis companies. Total return swaps are over-the-counter derivatives which provide the fund with exposure to the underlying reference assets (i.e. MSOs). Total return swaps introduce counterparty risk via prime brokers that the Fund engages with.

WEED May Provide Exposure To:
  • U.S. multi-state operators ("MSOs") like Curaleaf, Trulieve, GTI, and Verano, by gaining exposure via total return swaps.
  • Ancillary cannabis businesses such as Leafly, WM Technology (Weedmaps), and Innovative Industrial Properties.
  • Foreign cannabis companies, including Canadian operators such as Tilray and Canopy Growth.
Cannabis Sector Highlights:
  • The global legal cannabis market is expected to generate more than $61 billion in sales by 2026, more than doubling 2021's $29 billion in sales. (BDSA)
  • Cannabis is currently legal in some form in 37 U.S. states and Washington D.C, including 18 states which have regulated recreational markets. Positive regulatory momentum is expected to continue in coming years, with the densely populated Tri-State market (Connecticut, New York, New Jersey) expected to come online in 2022 and 2023. Legal U.S. cannabis sales are expected to surpass $28 billion in 2022. (Bloomberg Intelligence, BDSA)
  • Cannabis remains illegal at the federal level in the United States and potential federal legalization would represent a significant tailwind for the sector. In April 2022, the U.S. House of Representatives passed the MORE Act, which would serve to decriminalize cannabis on a federal level.

Investor Deck

NAV and Market Price

As of TBD

NAV Market Price
Net Asset Value Closing Price
Change ($) Change ($)
Change (%) Change (%)
WEED Performance

As of TBD




(as of TBD)
        Since Inception
Market Price        

Performance for periods greater than one year shown annualized. Net Asset Value (NAV) is the dollar value of a single share, based on the value of the underlying assets of the fund minus its liabilities, divided by the number of shares outstanding.

Gross Expense Ratio         0.75%
Net Expense Ratio         0.59%*

*The Advisor has agreed to waive 0.16% of its management fee for the Fund until at least April 30, 2023

The performance data quoted represents past performance. Past performance does not guarantee future results. Current performance may be lower or higher than the performance data quoted. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost. Returns less than one year are not annualized. For the most recent month-end performance, please call (855) 561-5728. You cannot invest directly in an index. Shares are bought and sold at market price (closing price), not net asset value (NAV), and are individually redeemed from the Fund. Market performance is determined using the Primary Exchange official closing price. Brokerage commissions will reduce returns.


as of TBD

Weight Name Ticker

ETF holdings and allocations are subject to change at any time and should not be interpreted as an offer of these securities.


As of TBD

NAV Premium/ Discount 30-day Median Bid/Ask Spread
$15.32 TBD TBD
Historical Premium/Discount
Days at premium
Days at NAV
Days at discount

How to buy the WEED ETF?

Roundhill ETFs trade intraday on an exchange. ETFs are available through various channels including broker-dealers, investment advisers, and other financial services firms, including:*


Interactive Brokers





BNY Mellon
WEED Cannabis ETF - FAQ


Investors should consider the investment objectives, risks, charges and expenses carefully before investing. For a prospectus or summary prospectus with this and other information about the WEED Cannabis ETF please call 1-855-561-5728 or visit the website at https://www.roundhillinvestments.com/etf/WEED. Read the prospectus or summary prospectus carefully before investing.

The statements and forecasts above are subject to significant business, economic, and competitive uncertainties. Accordingly, there can be no assurance that such statements, estimates and projections will be realized, and no representations are made as to the accuracy or completeness of such statements and forecasts. Such statements and forecasts are not indicative of future investment performance. ETF characteristics and allocations are subject to change at any time.

Investing involves risk, including possible loss of principal.

Companies involved in the cannabis industry face intense competition, may have limited access to the services of banks, may have substantial burdens on company resources due to litigation, complaints or enforcement actions, and are heavily dependent on receiving necessary permits and authorizations to engage in medical cannabis research or to otherwise cultivate, possess or distribute cannabis. Since the cultivation, possession, and distribution of cannabis can be illegal under United States federal law under certain circumstances, federally regulated banking institutions may be unwilling to make financial services available to growers and sellers of cannabis.

Cannabis-related companies are subject to various laws and regulations that may differ at the state/local and federal level. Laws and regulations related to the possession, use (medical or recreational), sale, transport and cultivation of marijuana vary throughout the world, and the Fund will only invest in non-U.S. Cannabis Companies if such companies are operating legally in the relevant jurisdiction. These laws and regulations may (i) significantly affect a cannabis-related company’s ability to secure financing, (ii) impact the market for marijuana industry sales and services, and (iii) set limitations on marijuana use, production, transportation, and storage.

In addition, cannabis-related companies are subject to the risks associated with the greater agricultural industry, including changes to or trends that affect commodity prices, labor costs, weather conditions, and laws and regulations related to environmental protection, health and safety. Cannabis-related companies may also be subject to risks associated with the biotechnology and pharmaceutical industries. These risks include increased government regulation, the use and enforcement of intellectual property rights and patents, technological change and obsolescence, product liability lawsuits, and the risk that research and development may not necessarily lead to commercially successful products.

As an ETF, the fund may trade at a premium or discount to NAV. Shares of any ETF are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Due to the costs of buying or selling Shares, including brokerage commissions imposed by brokers and bid/ask spreads, frequent trading of Shares may significantly reduce investment results and an investment in Shares may not be advisable for investors who anticipate regularly making small investments.

The Fund is a recently organized investment company with no operating history. Please see the prospectus for details of these and other risks.

Fund is distributed by Foreside Fund Services, LLC.
Foreside Fund Services and Roundhill Investments are unaffiliated companies.


*Neither Roundhill Investments nor WEED Cannabis ETF are affiliated with these financial services firms. Their listing should not be viewed as a recommendation or endorsement.